CARFILZOMIB | CARFILZOMIB | ATC L01XX45
ANTINEOPLATIC TREATMENT OF MULTIPLE MYELOMA PROTEASOME INHIBITOR THAT IRREVERSIBLY (COVALENTLY) BINDS TO THE N-TERMINAL THREONINE-CONTAINING ACTIVE SITES OF THE 20S PROTEASOME | INTRAVENOUS INJECTION | Cmax 5.8 MICROMOLAR VD 28 LITER PPB 97 PERCENT Cl 207 LITER / HOUR HT 1 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | 20S PROTEASOME | 26S PROTEOSOME INHIBITOR CHEMBL2364701 26S PROTEOSOME P28074 PROTEASOME SUBUNIT BETA HOMO SAPIENS ENZYME PROTEASE THREONINE PBT T1A | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |